AGNG

Weekly Report: what happened at AGNG last week (1127-1201)?

Weekly Report: what happened at AGNG last week (1120-1124)?

Weekly Report: what happened at AGNG last week (1113-1117)?

Biotech Sector Remains Under Pressure Despite Previous COVID Gains

Biotech sector faces challenges including higher interest rates, inflation, regulatory pressures, and a post-covid slump. Short interest remains high for some pharmaceutical companies, indicating bearish sentiment. Exchange-traded funds in the biotech sector have experienced outflows, reflecting a negative outlook. Increase in interest rates and higher than expected inflation are creating a tough environment for the sector.

Taking The Temperature Of Healthcare Stocks

Investors in healthcare stocks have underperformed the global market this year. But earnings growth forecasts are healthy and valuations look attractive, says alliancebernstein. Many growth trends in the healthcare sector are driven by the need for efficiency and cost savings. Active investors can find companies that benefit from durable business growth trends across the sector.

Weekly Report: what happened at AGNG last week (1106-1110)?

Weekly Report: what happened at AGNG last week (1030-1103)?

Weekly Report: what happened at AGNG last week (1023-1027)?